Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$315.92 - $397.36 $631 - $794
2 Added 5.0%
42 $13,000
Q2 2023

Aug 09, 2023

BUY
$346.15 - $392.09 $2,423 - $2,744
7 Added 21.21%
40 $15,000
Q1 2023

May 10, 2023

BUY
$323.56 - $373.36 $1,617 - $1,866
5 Added 17.86%
33 $12,000
Q4 2022

Feb 08, 2023

BUY
$248.67 - $334.17 $497 - $668
2 Added 7.69%
28 $9,000
Q3 2022

Nov 09, 2022

SELL
$263.81 - $337.27 $2,374 - $3,035
-9 Reduced 25.71%
26 $7,000
Q2 2022

Aug 12, 2022

BUY
$301.4 - $428.42 $5,726 - $8,139
19 Added 118.75%
35 $11,000
Q4 2021

Feb 14, 2022

BUY
$373.53 - $434.12 $373 - $434
1 Added 6.67%
16 $7,000
Q3 2021

Nov 12, 2021

BUY
$396.76 - $455.92 $5,951 - $6,838
15 New
15 $6,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.